Myo-Inositol Trispyrophosphate (ITPP) Liquid

Myo-Inositol Trispyrophosphate (ITPP) Liquid

Myo-Inositol Trispyrophosphate (ITPP) is the laboratory-made derivative of a naturally occurring compound, Myo-Inositol. Myo-Inositol is naturally produced in organisms that consist of a 6-carbon cyclic alcohol. When three pyrophosphate groups are added to its -OH side, it converts into a Myo-Inositol Trispyrophosphate compound. 

This converted ITPP has the potential to enter cell membranes in preclinical models and influence hemoglobin affinity for oxygen. Due to this potential, it has been studied in hypoxic conditions (low oxygen) and in topics related to oncology, cardiology, metabolism, and insulin resistance in preclinical models. 

How does it work?

According to preclinical research, ITPP has the potential to cross the cell membranes of red blood cells in organisms. This process reduces the hemoglobin’s grip on oxygen, allowing it to release more oxygen to various cells in preclinical models. This mechanism enhances oxygenation in multiple tissues of preclinical models where oxygen is scarce.

Properties of Myo-Inositol Trispyrophosphate Liquid (ITPP)

• Alternative Names: Myo-inositol trispyrophosphate, 116EYZ0PPX, 802590-64-3, DTXCID301514847, DTXSID301029636

• Molecular Formula: C6H12O21P6

• Molecular Weight: 605.99 g/mol

• CAS Number: 802590-64-3

Potential Experimental Benefits of Myo-Inositol Trispyrophosphate (ITPP) Liquid

The potential benefits of Myo-Inositol Trispyrophosphate (ITPP) liquid observed in preclinical models are as follows:

Potential Improvement in Tissue Oxygenation:

In experiments on preclinical models, ITPP liquid has shown potential to improve oxygenation. This oxygenation effect occurs when ITPP liquid crosses the cell membranes of cells and reduces hemoglobin affinity for oxygen in preclinical models. With reduced hemoglobin affinity, hemoglobin releases the stored oxygen to various tissues in preclinical models during experiments.  

Potential Influence on Mitigation of Hypoxia:

ITPP has also been studied for its potential to mitigate hypoxia (a condition of low oxygen levels) in preclinical models during laboratory experiments. During hypoxia, the cells in preclinical models are unable to receive sufficient oxygen supply. 

ITPP liquid triggers hemoglobin in preclinical models to release oxygen to tissues that lack oxygen supply. This mitigates hypoxia and affects the activities of HIF-alpha cells (HIF-alpha cells are oxygen-sensitive) in preclinical models during laboratory experiments.  

Influences Anti-Tumor Activities: 

Besides being used in hypoxic conditions, ITPP has also been experimented with for its influence on anti-tumor activities in preclinical models. In cancer studies, tissues are unable to receive sufficient oxygen supply. This triggers premature angiogenesis (the formation of abnormal blood vessels) in preclinical models, worsening the condition further.

ITPP liquid helps by providing sufficient oxygen, thereby reducing the abnormal formation of blood vessels in preclinical models. Due to this potential impact, ITPP is being studied for its anti-tumor activities in preclinical models during laboratory experiments. 

Why Choose BehemothLabz to Buy Myo-Inositol Trispyrophosphate (ITPP) Liquid

Start your research journey by ordering our premium quality Myo-Inositol Trispyrophosphate (ITPP) liquid online.

At BehemothLabz, we offer third-party verified and tested Myo-Inositol Trispyrophosphate (ITPP) liquid for sale. Our products are aligned with the industrial standards and the requirements of researchers, maximizing the chances of optimal results. Additionally, we provide our customers with a 24/7 customer representative service.

Additionally, our prices for products are reasonable and within the purchasing range, while maintaining high quality. Our products can be delivered nationally and internationally, with free shipping available for orders exceeding $100.

You won’t find any other place where you can buy Myo-Inositol Trispyrophosphate online. So place your order now and enjoy our premium product. 

Disclaimer: Our products are intended for laboratory research purposes. We strictly prohibit human consumption of our products. 

Frequently Asked Questions (FAQs)

Where to buy Myo-Inositol Trispyrophosphate (ITPP) online? 

The best place to buy ITPP liquid online is BehemothLabz. Here, the products are verified from third-party sources and are ready to deliver optimal research results. Moreover, the payment system is also safe and secure, protecting the personal information of customers. 

What is Myo-Inositol Trispyrophosphate (ITPP) used for in laboratory experiments? 

Myo-Inositol Trispyrophosphate (ITPP) liquid is used to study its impact on oxygenation in preclinical models during laboratory experiments. It is further investigated in studies related to areas of low oxygen in preclinical models. 

How long does ITPP last in preclinical models?

In preclinical models, ITPP lasts for approximately 12 days. Within the initial two days, the impacts are visible, with increased oxygen supply to tissues in preclinical models. Over time, the impacts gradually reduce and reach 50% by day 5. By day 12, the impacts completely disappear from preclinical models. 

Is ITPP safe to use in laboratory experiments?

Yes, ITPP is safe to use in laboratory experiments. It does not cause severe side effects, except for mild to moderate ones, in preclinical models. However, these side effects can be easily managed by following established research guidelines.

Form	Liquid
Strength	33mg per ml/30ml/1000mg